Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoproliferative Disorders × pomalidomide × Clear all

Sponsor

Conditions

Multiple Myeloma 41 Recurrence 10 Neoplasms, Plasma Cell 6 Primary Myelofibrosis 3 Waldenstrom Macroglobulinemia 2 Polycythemia Vera 2 Myeloproliferative Disorders 2 Thrombocythemia, Essential 1 Smoldering Multiple Myeloma 1 Sarcoma, Kaposi 1 Sarcoma 1 Plasmacytoma 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Plasma Cell 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Immunoglobulin Light-chain Amyloidosis 1 Hodgkin Disease 1 Glioma 1 Ependymoma 1 Central Nervous System Neoplasms 1 Carcinoma, Small Cell 1 Brain Neoplasms 1

Interventions

blinatumomab 6 Tacrolimus 3 Rituximab 3 Cyclophosphamide 3 ponatinib 2 fludarabine 2 Vorinostat 2 Vincristine 2 Prednisone 2 Peripheral Blood Stem Cell Transplantation 2 Methotrexate 2 Everolimus 2 Etoposide 2 Doxorubicin 2 Darbepoetin alfa 2 Busulfan 2 Brentuximab Vedotin 2 Antilymphocyte Serum 2 tetulomab tetraxetan lu-177 1 ruxolitinib 1 pegaspargase 1 ibritumomab tiuxetan 1 fludarabine phosphate 1 ferrous sulfate 1 ferric gluconate 1 denileukin diftitox 1 cobomarsen 1 asparaginase erwinia chrysanthemi recombinant 1 Tomography, X-Ray Computed 1 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡